Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TARS | AMGN | VRTX | REGN | BMY |
| Company | Tarsus Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 38.95 | 308.73 | 429.07 | 980.00 | 45.38 |
| High | 39.54 | 312.40 | 429.93 | 987.80 | 45.72 |
| Low | 37.60 | 307.47 | 422.44 | 970.95 | 44.53 |
| Last | 37.89 | 311.49 | 431.99 | 984.87 | 44.73 |
| Change | -0.48 | +3.04 | +2.06 | +7.91 | -0.33 |
| % Change | -1.25% | +0.99% | +0.48% | +0.81% | -0.73% |
| Volume | 477,400 | 1,164,409 | 570,699 | 214,657 | 9,196,985 |
| 20-Day Average Volume | 584,361 | 2,873,534 | 1,075,179 | 451,893 | 14,017,350 |
| Previous Close | 38.37 | 308.45 | 429.93 | 976.96 | 45.06 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 34.50 | 286.07 | 405.26 | 927.50 | 45.66 |
| 20-Day Raw Stochastic | 62.77% | 82.62% | 93.19% | 98.50% | 24.44% |
| 20-Day Relative Strength | 58.12% | 66.05% | 64.09% | 63.93% | 36.87% |
| Weighted Alpha | +160.35 | +38.46 | +26.07 | +31.48 | -32.56 |
| Today's Opinion | 100% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.26% since 05/07/24 | +3.84% since 05/07/24 | +4.29% since 05/07/24 | +1.62% since 05/07/24 | +1.85% since 05/07/24 |
| Low | 33.76 on 05/09/24 | 298.89 on 05/08/24 | 412.12 on 05/08/24 | 952.14 on 05/08/24 | 43.49 on 05/09/24 |
| High | 42.50 on 05/09/24 | 314.89 on 05/10/24 | 430.52 on 05/13/24 | 987.38 on 05/14/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | +4.87% since 04/12/24 | +16.67% since 04/12/24 | +7.89% since 04/12/24 | +8.95% since 04/12/24 | -7.09% since 04/12/24 |
| Low | 30.23 on 04/30/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 42.50 on 05/09/24 | 322.60 on 05/03/24 | 430.52 on 05/13/24 | 987.38 on 05/14/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +22.28% since 02/14/24 | +7.51% since 02/14/24 | +2.38% since 02/14/24 | +4.00% since 02/14/24 | -8.25% since 02/14/24 |
| Low | 28.42 on 03/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 42.50 on 05/09/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +111.66% since 11/14/23 | +15.49% since 11/14/23 | +15.65% since 11/14/23 | +24.19% since 11/14/23 | -11.21% since 11/14/23 |
| Low | 15.60 on 12/04/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 784.96 on 11/15/23 | 43.33 on 05/02/24 |
| High | 42.50 on 05/09/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,449,695 | 165,463,376 | 110,944,728 | 107,647,312 | 91,341,128 |
| Shares Outstanding, K | 37,782 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 17,450,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -135,890,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 27,610,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -35,730,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 1.10 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.01 on 05/08/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/08/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.65 | 28.07 | 26.24 | 42.80 |